John D. Loike and Alan Kadish | Jun 14, 2018 | 4 min read
The use of pronuclear transfer to treat infertility must first be backed by evidence it can work in cases where parents seek to avoid mitochondrial mutations.
The country’s fertility regulator has approved the first application to carry out mitochondrial replacement therapy, which uses biological material from two women and one man to create an embryo.
Bob Grant, Jef Akst, and Tracy Vence | Dec 23, 2016 | 5 min read
This year, the developers of CRISPR gene-editing technology argued over patent rights, a researcher fought to unmask anonymous PubPeer commenters, US regulators considered “three-parent” babies, and troubles continued for Theranos.
Parliament voted to allow mitochondrial replacement therapy last year. This latest decision suggests we may see babies born from the technique in the country in 2017.
Differences in the replicative advantages conferred by some mitochondrial DNA haplotypes have implications for mitochondrial replacement therapy, researchers report.
Parliament today voted to allow techniques that could help couples produce babies with a reduced chance of passing on heritable mitochondrial diseases.
The U.K.’s human embryo research agency says that a new mitochondrial replacement technique is safe and could be approved soon, paving the way for three-parent IVF.
Regulators in England near the approval of a new mitochondrial replacement technique for creating embryos with less risk of developing certain heritable diseases.